Biosynex Nordic ApS: Financial statements 2017
CVR: 38417541
Source: annual report 2017, Danish Business Authority
09/02/2017 – 31/12/2017
Biosynex Nordic ApS (CVR 38417541) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 355,509 and a net result of DKK 664. The profit margin was 0.2%. Equity in the 2017 report amounted to DKK 50,664. The solvency ratio was 15.3%.
- Revenue
- DKK 355,509
- Gross Profit
- DKK 840
- Profit/Loss
- DKK 664
- Equity
- DKK 50,664
- Total Assets
- DKK 331,405
Official annual report
Keep an eye on Biosynex Nordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of February 9, 2017, Suzanne Flagstad is registered as director of Biosynex Nordic ApS.
Biosynex Nordic ApS was founded on February 9, 2017.
About Biosynex Nordic ApS
Biosynex Nordic ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 7 July 2025. The company was registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter. The company was previously named Biosynex Nordic A/S and Medkoncept A/S. The company has 2 employees (2025). In 2023, the company reported a gross profit of DKK -1,062,001 and a net result of DKK -3,931,794 compared with DKK 41,802,660 the year before. Equity in the 2023 report amounted to DKK -3,814,178.